CTI BIOPHARMA
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 24 Mar 2023)
What this means for you
Registered since 21 Mar 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86282220
- Registration number
- 5166752
- Mark type
- Stylized text
- Filed
- 15 May 2014
- Published for opposition
- 15 Dec 2015
- Registered
- 21 Mar 2017
- Attorney of record
- Frances M. Jagla
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of cancer and for use in chemotherapy treatment; Pharmaceutical preparations and substances for the treatment of immunological, oncological, inflammatory and infectious diseases and disorders; Pharmaceutical preparations used for the treatment of conditions secondary to the oncologic, immunological and inflammatory diseases; Pharmaceutical preparations and substances for the management and treatment of pain accompanying either the disease process or the associated treatment regimens
- Class 041 — Education and entertainment services: Conducting seminars, classes, workshops, and training in the fields of pharmaceutical products and the treatment of medical disorders, the life sciences, clinical trials, health, medicine, oncology, hematology, cancer, and genetic disorders, and providing course materials in connection therewith; Online publications in the nature of articles, journals, and newsletters in the fields of pharmaceuticals and the treatment of medical disorders, the life sciences, clinical trials, health, medicine, oncology, hematology, cancer, and genetic disorders
- Class 042 — Scientific and technological services: Research, development, engineering, testing, product evaluation, and inspection in the field of pharmaceutical preparations and products; Pharmaceutical research and development; Providing technical consultation in the field of pharmaceutical product research and development; Medical and scientific research, namely, conducting clinical trials for others for pharmaceutical preparations used for the treatment of cancer, immunological, inflammatory and infectious diseases, and pain; Scientific research, consulting, and advice in the fields of biotechnology, pharmaceutical research and development, and the life sciences; Pharmaceutical, medical and laboratory research services in the fields of pharmaceuticals, cancer, genetic disorders, and the life sciences; Providing medical testing services for research purposes and medical and scientific research information in the fields of pharmaceuticals, the life sciences, clinical trials, medicine, oncology, hematology, cancer, disease classification, and genetic disorders; and consultation related to the foregoing
Owner
- CTI BIOPHARMA CORP., SEATTLE, WA, US
- CTI BIOPHARMA CORP., SEATTLE, WA, US
- CTI BIOPHARMA CORP., SEATTLE, WA, US
- Cell Therapeutics, Inc., Seattle, WA, US
Prior registrations
Prosecution history
- 21 Mar 2026 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 24 Mar 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 24 Mar 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 24 Mar 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 13 Sept 2022 — TEAS SECTION 8 & 15 RECEIVED
- 21 Mar 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 12 Jun 2020 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 14 May 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 14 May 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 14 May 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 14 May 2020 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 14 May 2020 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 06 May 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 06 May 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 06 May 2020 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS